Merck, Pfizer and Verastem announce combination trial of avelumab and VS-6063 in ovarian cancer
|
04 March 2016 |
Pfizer names executive leadership team for combined organization upon close of proposed Allergan transaction
|
08 February 2016 |
Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals
|
02 February 2016 |
Pfizer expands R&D equity investment strategy to access early-stage scientific innovations
|
13 January 2016 |
Merck KGaA, Darmstadt, Germany, Pfizer and Syndax announce collaboration to evaluate combination of Avelumab and Entinostat in ovarian cancer
|
04 January 2016 |
Global partners announce donation of 500 millionth dose of azithromycin
|
17 November 2015 |
Pfizer expands its patient assistance program
|
10 November 2015 |
Pfizer completes acquisition of Nimenrix and Mencevax from GlaxoSmithKline
|
06 October 2015 |
New Centrum® VitaMints® offer a refreshingly new way to take a multivitamin
|
24 September 2015 |
Pfizer and Synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis
|
04 August 2015 |
Pfizer's Centers for Therapeutic Innovation and Jeffrey Modell Foundation announce collaboration
|
13 July 2015 |
Pfizer enters into agreement to acquire Nimenrix and Mencevax from GlaxoSmithKline
|
23 June 2015 |
Get Ready. Get Set. Get Old.
|
04 June 2015 |
Pfizer announces $3 million grants program to further clinical research in advanced breast cancer
|
28 May 2015 |
Pfizer acquires minority interest in AM-Pharma; secures option to acquire company
|
11 May 2015 |
Pfizer and Lilly preparing to resume Phase 3 chronic pain program for Tanezumab
|
23 March 2015 |
Pfizer to Acquire Hospira
|
06 February 2015 |
Acquisition provides Pfizer with a preclinical CMV vaccine candidate
|
09 January 2015 |
Pfizer expands rare disease research with establishment of gene therapy platform
|
08 December 2014 |
Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study
|
30 September 2014 |